Logo

PerkinElmer s Predictive Diagnostics s Biomarker Amplification Filter and prOTOF 2000 MALDI-TOF

Sep 30, 2004
Premium

PerkinElmer will provide access to Predictive Diagnostics’s Biomarker Amplification Filter technology customized for PerkinElmer’s prOTOF 2000 MALDI-TOF, PerkinElmer said this week. PerkinElmer will offer PDI’s BAMF Technology services to pharmaceutical companies and research institutions, the company added. PDI’s BAMF Technology is a suite of in silico “machine-learning technologies” and informatics tools that use a “simple” blood test for the discovery of biomarker fingerprints to diagnose diseases using high-resolution mass spectrometry data, said PerkinElmer. The technology is intended for use in serum-based tests for early diagnosis of cancer and other life-threatening diseases, the company added.

 

Filed under

Diagnostics
Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.